Articles tagged with Autoimmune Disorders
Researchers found that mutations in one copy of the AIRE gene can cause symptoms of a rare autoimmune disorder, paving the way for specific diagnostic and treatment strategies. Dominant AIRE mutations are also more common than previously thought, occurring in at least 1 in 1,000 individuals.
Researchers have found that narcolepsy bears the hallmarks of a classic autoimmune disorder, with a particular autoantibody process triggering the loss of orexin neurons. This discovery opens up new avenues for diagnosis and treatment, potentially leading to a better understanding of the disease.
A blood test can help doctors predict which patients with an autoimmune disease are at risk of relapse, potentially preventing kidney failure. Researchers found that autoantibody increases were linked to an 11-fold increased risk of relapse in patients with kidney involvement.
The article highlights the role of pattern recognition receptors in regulating immune responses and their potential as novel targets for developing potent new therapies. The JAK/STAT signaling network also plays a crucial role in disease pathogenesis, and targeting these networks may lead to improved treatments for various diseases.
Researchers discovered a paradoxical immune protein that both helps and hinders the immune system response, leading to increased susceptibility to rare bacterial infections and predisposition to autoimmune diseases. The protein ISG15 plays a crucial role in resolving inflammation and preventing autoinflammatory disorders.
A new study suggests that an autoimmune response may contribute to the development of high blood pressure. Using mouse models, researchers found that compounds stimulating hypertension led to the faulty production of modified proteins in dendritic cells, triggering an immune response.
Researchers from the University of Buffalo have discovered new details of how autoantibodies destroy healthy cells in skin, providing insights into autoimmune mechanisms that could help develop and screen treatments for patients suffering from all autoimmune diseases. The study uses atomic force microscopy to analyze cell junctions and...
A study by Penn Medicine researchers found a common genetic link among patients with pemphigus vulgaris, a blistering skin disease. The researchers identified a particular gene, VH1-46, that was used by PV antibodies across all four patients, suggesting common mechanisms for developing the disease.
Researchers found that all-trans retinoid acid enhances a key subset of T cells that promote immune system tolerance. This finding suggests the potential use of Vitamin A to treat autoimmune diseases and protect organ recipients.
Professor Richard Pleass of LSTM has developed a biomimetic called Hexagard, which is approximately 50 fold more effective than current IVIG therapy. The innovative treatment aims to replace IVIG therapy for treating autoimmune diseases in developing countries where it is unaffordable.
A large group of U.S. patients with PSC and primary biliary cirrhosis showed an association between coffee consumption and reduced risk of PSC. The study suggests that PSC differs from primary biliary cirrhosis in terms of lifestyle factors, potentially offering new insights into disease causes and treatment.
A new study found that coffee consumption is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune disease of the bile ducts. Researchers also highlighted the need for better palliative care for terminally ill cirrhotic patients, who often face significant symptoms and challenges.
Researchers have linked 17 genes to juvenile idiopathic arthritis, a significant increase from previous findings of three genes. The study analyzed over 2,800 patient DNA samples and provides new insights into the disease process.
A study published in PLOS ONE found that vitamin D supplements improved gene expression related to cancer, autoimmune diseases, and cardiovascular disease. The researchers observed significant alterations in the activity of 291 genes, with biologic functions associated with 160 biologic pathways linked to these diseases.
Researchers at UCSB have developed inexpensive medical diagnostic tests that can detect a wide range of diseases in under five minutes, using nanometer-scale DNA switches. The new technology has the potential to significantly impact world health by eliminating the lag between testing and treatment.
A new University of Nottingham study will examine the incidence and impact of gluten intolerance in the UK, focusing on coeliac disease and dermatitis herpetiformis. The research aims to improve diagnosis rates and healthcare for affected individuals, with a goal of creating a more accurate estimate of the condition's prevalence.
The study found five significant genetic associations for hypothyroidism, including rs6679677 near PTPN22 and rs925489 near FOXE1, which contribute to understanding the underlying biology of the disease. The results also highlight potential pathways of treatment for autoimmune diseases.
Researchers identified a special class of fatty molecules essential for activating immune cells, offering new opportunities for therapeutic interventions. The discovery sheds light on how recognition of these stimulatory fatty molecules by immune cells protects against infection, autoimmune diseases, and cancer.
Chronic psychological stress is associated with a loss of ability to regulate inflammatory response, promoting disease development. Inflammation plays a key role in various diseases like cardiovascular and autoimmune disorders.
A genetic mutation in the PLCG2 gene causes a rare immune disorder characterized by excessive and impaired immune function, leading to symptoms such as cold-induced hives, immune deficiency, and autoimmunity. The study identifies a unique genetic mechanism at the crux of allergy, immune defense, and self-tolerance.
Researchers have eliminated two possible causes of joint pain in women taking breast cancer medications: inflammatory arthritis and autoimmune disease. Despite finding no link between the medication and these conditions, doctors recommend continuing treatment to gain full benefits.
Transplantation specialists propose changes to liver organ distribution to prioritize patients with high MELD scores and reduce waitlist mortality. The new model aims to rapidly allocate organs to those most in need, ensuring timely delivery and reducing death rates.
Researchers have discovered that a specific type of T-cell can kill neurons, raising concerns about the potential effectiveness of an MS therapy. The study found that these protective T-cells, which are meant to regulate the immune system, can instead cause autoimmune diseases like MS.
Researchers at TU Delft are developing an objective, quantitative method to assess MRI scans for Crohn's disease activity. This new method aims to improve disease monitoring and reduce the need for colonoscopies, a stressful procedure.
Researchers at Georgetown University Medical Center found no conclusive evidence linking joint complaints to inflammatory arthritis or autoimmune disease in women taking aromatase inhibitors. However, they suggest encouraging women to continue taking the medication despite joint pain.
A team of researchers is studying the human gut microbiome to develop new interventions and treatments for food- and water-borne diseases. The study aims to understand how certain microbes protect against enteric diseases and identify potential therapeutic targets.
Two UNC School of Medicine faculty authored an editorial discussing the results of two clinical trials using Rituximab to treat small-vessel vasculitis, a rare autoimmune disease. The trials showed that Rituximab was effective in inducing remission compared to other treatments.
Researchers at Oregon State University discovered that the genetic regulator Ctip2 controls the formation of T cells, a type of white blood cell crucial for immune function. This finding may lead to new immune system-based therapies for diseases like HIV/AIDS and autoimmune disorders.
Researchers have discovered a gene linked to a newly recognized multisystem autoimmune disorder affecting Amish children, characterized by chronic diarrhea, enlarged organs, and developmental delays. The ITCH gene plays a crucial role in regulating the immune system, and identifying it may lead to effective treatment for these children.
A new study identifies autoantibodies targeting Trib2 protein in narcolepsy patients with cataplexy, supporting the theory that narcolepsy is an autoimmune disorder. Elevated levels of these antibodies were found in narcolepsy patients, furthering research on the underlying causes of the condition.
A new study finds that fibrocytes, a type of immune cell, are present at higher frequencies in patients with Graves' disease, leading to scarring and inflammation in the orbit. This discovery may lead to new treatments targeting scarring or fibrosis.
A study of 357 patients who underwent rhinoplasty using irradiated homologous costal cartilage found low complication rates, including 3.25% warping, infection, or resorption. Patient satisfaction was high at 94.2%, making this graft material a reliable alternative to autologous cartilage.
Researchers at NIEHS found an association between UV radiation and the frequency of dermatomyositis in women. Women with higher UV levels were more likely to develop this form of myositis, which weakens muscles and causes distinctive rashes.
A new mouse model reveals that innate immunity plays a key role in driving symptoms of auto-inflammatory diseases. The study shows that the innate immune system is responsible for the over-activation leading to inflammation and symptoms.
Research suggests that supplementing with vitamin D can exacerbate autoimmune diseases by deactivating the immune response and allowing bacteria to spread more easily. The form of vitamin D derived from food and supplements, 25-hydroxyvitamin D, is a secosteroid rather than a vitamin.
Researchers at Uppsala University have discovered a previously unknown protein in the lungs that plays a crucial role in an autoimmune lung disorder. This breakthrough may lead to new diagnostic methods and insights into common public health disorders like asthma and chronic bronchitis.
Researchers found that deleting furin in helper T cells led to autoimmune disease in mice, highlighting the importance of regulatory and effector T cell balance. The study's findings have implications for developing drugs to increase immune response in diseases like cancer and HIV.
Researchers deliver genetically engineered T-reg cells to the intestine to suppress inflammation and autoimmunity. The 'bystander' effect enables these cells to target diseased tissue, suppressing inflammatory cells and promoting healing.
Researchers have identified a protein, NALP5, that plays a crucial role in autoimmune disorders such as APS-1. The discovery provides new insights into the first phase of autoimmune responses and opens up possibilities for developing treatments.
Recent research suggests adult stem cells from blood or marrow may provide treatment benefits for certain autoimmune diseases and cardiovascular disorders. The studies indicate that these cells can contribute to modest improvement in cardiac function, but more clinical trials are needed to determine their effectiveness.
A new study identifies a connection between allergic diseases like eczema and autoimmune diseases, suggesting that these conditions may trigger each other through immune system dysfunction. The researchers are now investigating specific triggers and exploring potential treatments, including drugs that can counter autoimmune responses.
A study by Yale University researchers found that caspase 3 and caspase 7 are crucial for apoptosis, a process essential for embryonic development and immune system function. Mice lacking these proteins died within the first day of life due to defective cardiac development.
A new model of the immune system predicts that chronic infections can lead to autoimmune diseases. Researchers developed a biologically-plausible strategy for the immune system to react more quickly and effectively against disease.
Researchers found that bacterial infections can activate self-reactive B cells with significant affinity, driving them to mature into harmful memory B cells. This activation is facilitated by the cooperation of autoantigens, innate immunity, and T cells.
Researchers at Wyeth determined the three-dimensional structure of PKCΘ, a key signaling molecule in T lymphocytes. This discovery has potential to identify selective inhibitors for autoimmune diseases by disabling T cell activation.
A Mayo Clinic study found that most children with juvenile dermatomyositis (JDM) carry a particular gene from their mother, triggering an immune response. The research suggests that maternal cells may play a role in the development of JDM, a rare condition that causes inflammation and muscle damage.
Activation of antigen-presenting cells (APCs) by microbial products leads to the breakdown of self-tolerance in the immune system. This breakdown induces autoimmune disease, a condition where the immune system mistakenly attacks healthy tissues.
Researchers at UCSD identified a key gene pathway contributing to pulmonary hypertension, with potential molecular targets for new therapies. The study revealed that abnormal expression of angiopoietin-1 leads to muscle cell proliferation in lung vessels, causing disease progression.
Scientists are developing an encyclopedia of innate immune system activity using systems biology approaches. This could lead to a better understanding of inflammation and its control, potentially revealing targets for new drugs. The study also explores the use of bioinformatics resources to support research on immune-mediated diseases.